Weight loss drugs, including Wegovy and Ozempic, are being considered by individuals for weight loss, with several alternatives available. Some of these alternatives have been approved by the FDA, while others may have varying levels of accessibility, including potential limitations in Medicaid coverage. The effectiveness and potential benefits of these drugs, including a possible link to lower breast cancer risk, are being reported and explored.